Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GARY F WILLEN

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1700857422
CMS profile
304440
Location
CARSON CITY, NV

General Payments · PY2018–2024

$6,152.72

  • Reported across 189 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$262.85

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $245.41 13
Education $17.44 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Astellas Pharma US Inc $191.82 10
Sumitomo Pharma America, Inc. $53.59 3
PFIZER INC. $17.44 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,497.80 29
PY2019 $1,985.36 39
PY2020 $241.09 14
PY2021 $1,345.17 48
PY2022 $486.10 27
PY2023 $334.35 18
PY2024 $262.85 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $19.98 01/08/2024 Food and Beverage Undisputed 01/23/2026 1139312098 CMS
Astellas Pharma US Inc $23.14 02/19/2024 Food and Beverage Undisputed 01/23/2026 1139313424 CMS
Astellas Pharma US Inc $27.62 04/15/2024 Food and Beverage Undisputed 01/23/2026 1139320624 CMS
Astellas Pharma US Inc $11.53 05/02/2024 Food and Beverage Undisputed 01/23/2026 1139335818 CMS
Astellas Pharma US Inc $22.52 05/30/2024 Food and Beverage Undisputed 01/23/2026 1139358149 CMS
Astellas Pharma US Inc $13.12 07/10/2024 Food and Beverage Undisputed 01/23/2026 1139281936 CMS
Astellas Pharma US Inc $17.01 07/31/2024 Food and Beverage Undisputed 01/23/2026 1139270462 CMS
Astellas Pharma US Inc $11.05 08/27/2024 Food and Beverage Undisputed 01/23/2026 1139381790 CMS
Astellas Pharma US Inc $15.78 10/30/2024 Food and Beverage Undisputed 01/23/2026 1139421709 CMS
Astellas Pharma US Inc $30.07 11/14/2024 Food and Beverage Undisputed 01/23/2026 1139436418 CMS
PFIZER INC. $17.44 04/03/2024 Education Undisputed 01/23/2026 1131430648 CMS
Sumitomo Pharma America, Inc. $14.65 04/25/2024 Food and Beverage Undisputed 01/23/2026 1148935535 CMS
Sumitomo Pharma America, Inc. $23.05 07/16/2024 Food and Beverage Undisputed 01/23/2026 1148935537 CMS
Sumitomo Pharma America, Inc. $15.89 11/20/2024 Food and Beverage Undisputed 01/23/2026 1148935539 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.